ARTICLE | Clinical News
DecisionDx-Melanoma test: Data
June 17, 2013 7:00 AM UTC
Data from an independent validation study of 92 melanoma tumor samples showed that patients with tumors classified as Class 1 - low risk of metastasis - by Castle Biosciences' DecisionDx-Melanoma test...